Kailera Therapeutics KLRA
NASDAQ KLRA
$13.27 +0.06 (+0.45%)
At close: Nov 13, 2026 · 4:00 PM EST

Kailera Therapeutics (KLRA) Change in Account Payables (2025 - 2026)

Updated

Kailera Therapeutics (KLRA) reported Change in Account Payables of -$9.77 million for Q3 2026, compared with $154,000 a year earlier.

Analysis

Kailera Therapeutics (KLRA) Change in Account Payables (2025 - 2026) Analysis & Trends

Over the twelve months ended Sep 30, 2026, Kailera Therapeutics' Change in Account Payables came in at $6.8 million; for FY2025, it came in at $4.69 million, up 133.6% from FY2024.

  • By year, Change in Account Payables came in at $2.01 million in FY2024.
  • Per Business Quant data, the three quarters before Q3 2026 came in at $12.34 million (Q2 2026), -$495,000 (Q1 2026) and $4.73 million (Q4 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Change Payables (Qtr)
1 Eli Lilly 1,359.75 Bn 1,333.37 Bn 20.46 Bn -
2 Johnson & Johnson 688.76 Bn 608.62 Bn 17.30 Bn -
3 AbbVie 521.69 Bn 489.75 Bn 13.12 Bn -
4 Merck 364.31 Bn 327.31 Bn 13.19 Bn -
5 Novartis Ag 306.35 Bn 279.93 Bn - -
6 Astrazeneca 285.96 Bn 259.56 Bn 13.26 Bn -
7 Amgen 251.88 Bn 203.53 Bn 7.58 Bn 83.00 Mn
8 Gilead Sciences 208.59 Bn 183.61 Bn 6.73 Bn 254.00 Mn
9 Pfizer 164.73 Bn 112.38 Bn 12.56 Bn -
10 Kailera Therapeutics 1.72 Bn -1.16 Bn - -9.77 Mn
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 -9.77 Mn
Jun 30, 2026 12.34 Mn
Mar 31, 2026 -495,000.00
Dec 31, 2025 4.73 Mn
Sep 30, 2025 154,000.00
Jun 30, 2025 -837,000.00
Mar 31, 2025 645,000.00
API Access

Kailera Therapeutics Change in Account Payables API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=change-in-account-payables&ticker=KLRA&period=max&api_key=YOUR_API_KEY